Why pharma teams are drowning in submissions and what to do about it – Part two

Welcome to part two of this blog series. In the first part we’ve explored the current state of the pharma industry and how the regulatory submissions process has been impacted. We’ve looked at KPIs that sponsors and CROs can monitor to ensure regulatory submission success, and we’ve analyzed the current landscape, looking at the internal and external challenges organizations face when creating regulatory dossiers under tight deadlines. Going forward, we will define the key areas organizations must assess to leverage technology optimally, transforming both regulatory content processes and the working lives of staff. New ways of working  In part one, we’ve identified the challenges organizations face when producing regulatory content.